Kemena, A <br/><br/>
Inhibition of fludarabine metabolism by arabinosylcytosine during therapy.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1992 
 - 193-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00685547  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Arabinonucleotides--pharmacokinetics<br/>Cytarabine--administration & dosage<br/>Deoxycytidine Kinase--metabolism<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Phosphorylation<br/>Time Factors<br/>Vidarabine--administration & dosage